We believe new treatments should be brought to patients, rather than patients having to travel to receive help. To do this, we are establishing a network of sites across Australia that can rapidly identify patients suitable for new trials, utilising artificial intelligence software to accelerate patient-to-trial matching. In parallel, we are working with companies to bring more trials into Australia.
We aim to significantly reduce the administrative burden associated with establishing a trial by harmonising governance, accelerating ethics approval processes and improving site-level capabilities. Ultimately, patients benefit with easier access to a broader range of trials in their local area.
Research is essential to the discovery of new treatments. For patients with cancer, we need a better and quicker way to identify and increase the number of accessible trial opportunities to eliminate the need for a patient to travel interstate or overseas.
The project works with potential trial sponsors to establish trials within the ECI network, giving patient’s access to potentially life-saving medicine that may not have been not destined for Australia or made available at multiple sites.
In Australia, ECI has launched a country-wide collaborative trials platform with three major cancer centres – Linear Clinical Research, the Olivia Newton-John Cancer & Wellness Research Centre, and Chris O’Brien Lifehouse. The Network is in the process of expanding locally.
Our long-term goal is that any patient being treated at one of the centers as part of the ECI Clinical Trial Network (ECI-CTN) will have access to greater treatment options, including participation in a relevant clinical trial.